Riskpilot← Back to searchSign inGet full accessR. DONS' VANDANALYTISK LABORATORIUM A/S
A/SActiveCVR 32571468Blokken 43Technical testing and analysis · NACE 7120Est. 200910 employeeswww.donslab.dk
Revenue 2025
DKK 5,6M
+49% vs 2024
EBITDA margin
47.6%
+305% vs 2024
Equity ratio
65.0%
Financial strength
Net profit 2025
DKK 1,6M
+1926% vs 2024
| Revenue | DKK 5,6M | +49% |
| EBITDA | DKK 2,7M | +305% |
| Net profit | DKK 1,6M | +1926% |
| Total assets | DKK 6M | +23% |
| Equity | DKK 3,9M | +66% |
| Employees | 10 | — |
Legal name
R. DONS' VANDANALYTISK LABORATORIUM A/S
CVR number
32571468
Legal form
Aktieselskab
NACE code
7120 · Technical testing and analysis
Founded
24. november 2009
Share capital
DKK 500.000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør, eller 2 medlemmer af bestyrelsen, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive vandanalytisk laboratorium, samt yde anden teknisk rådgivning og undervisning.
Address
Blokken 43
Phone
+4545803120
Email
info@donslab.dk
Website
www.donslab.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5.299 | 3.310 | 3.827 | 3.770 | 5.607 |
| Staff expenses | -2.451 | -2.906 | -2.727 | -3.034 | -2.907 |
| EBITDA | 2.849 | 403 | 1.100 | 659 | 2.668 |
| Depreciation & amort. | -332 | -404 | -374 | -477 | -521 |
| EBIT | 2.517 | -1 | 725 | 182 | 2.147 |
| Net financials | 14 | -219 | -113 | -76 | -35 |
| Profit before tax | 2.531 | -220 | 612 | 106 | 2.112 |
| Tax | 545 | -45 | 138 | 24 | 464 |
| Net profit | 1.986 | -176 | 474 | 81 | 1.648 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4.506 | 4.337 | 4.363 | 4.881 | 6.010 |
| Equity | 2.876 | 2.201 | 2.675 | 2.356 | 3.904 |
| Long-term debt | 324 | 770 | 757 | 1.138 | 126 |
| Short-term debt | 1.261 | 1.367 | 839 | 1.270 | 1.803 |
| Total debt | 1.585 | 2.137 | 1.596 | 2.408 | 1.929 |
EBITDA margin
47.6%
This company
15.8%
Market median
+201% vs market
20212025
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20212025
Return on equity
42.2%
This company
18.4%
Market median
+129% vs market
20212025
Net profit margin
29.4%
This company
8.1%
Market median
+263% vs market
20212025
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20212025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MJ Management | Management | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2009 | |
| Chairman | 2009 | |
| Former (1) | ||
| Board of Directors | 2009 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2023 | |
| Company | 25–33.32% | 33.33–49.99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MORTEN DUE HOLDING ApS
R. DONS' VANDANALYTISK LABORATORIUM A/S Board members of R. DONS' VANDANALYTISK LABORATORIUM A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Johannes Due | Management | 0 companies |
| Helge Erhard Sørensen | Board of Directors | 0 companies |
| Karin Marie Due Spanggaard | Board of Directors | 0 companies |
| Jørn Andreas Due | Chairman | 0 companies |